Ubiquitin-specific protease 22: a novel molecular biomarker in cervical cancer prognosis and therapeutics (Q47692790)

4 February 2018

title

Ubiquitin-specific protease 22: a novel molecular biomarker in cervical cancer prognosis and therapeutics (English)

1 reference

4 February 2018

1 reference

cervix uterine cancer

1 reference

Meng Yang

1

1 reference

4 February 2018

Yun-Duo Liu

2

1 reference

4 February 2018

Yan-Ying Wang

3

1 reference

4 February 2018

Tian-Bo Liu

4

1 reference

4 February 2018

Ting-Ting Ge

5

1 reference

4 February 2018

Ge Lou

6

1 reference

4 February 2018

publication date

27 August 2013

1 reference

4 February 2018

published in

Tumor Biology

1 reference

4 February 2018

volume

35

1 reference

4 February 2018

issue

2

1 reference

4 February 2018

page(s)

929-934

1 reference

4 February 2018

https://scigraph.springernature.com/pub.10.1007/s13277-013-1121-4

exact match

0 references

cites work

Cancer in the developing world: a call to action.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1121-4

Global cancer statistics, 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1121-4

21 January 2018

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1121-4

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1121-4

Epidemiologic classification of human papillomavirus types associated with cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1121-4

Natural history and epidemiology of HPV infection and cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1121-4

American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1121-4

Targeting the ubiquitin system in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1121-4

The expression patterns of deubiquitinating enzymes, USP22 and Usp22

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1121-4

Genomic models of metastatic cancer: functional analysis of death-from-cancer signature genes reveals aneuploid, anoikis-resistant, metastasis-enabling phenotype with altered cell cycle control and activated Polycomb Group (PcG) protein chromatin si

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1121-4

A TFTC/STAGA module mediates histone H2A and H2B deubiquitination, coactivates nuclear receptors, and counteracts heterochromatin silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1121-4

The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1121-4

USP22, an hSAGA subunit and potential cancer stem cell marker, reverses the polycomb-catalyzed ubiquitylation of histone H2A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1121-4

Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1121-4

The history of cancer epigenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1121-4

The epigenomics of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1121-4

"Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1121-4

Aberrant expression of USP22 is associated with liver metastasis and poor prognosis of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1121-4

Increased expression of ubiquitin-specific protease 22 can promote cancer progression and predict therapy failure in human colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1121-4

Elevated expression of USP22 in correlation with poor prognosis in patients with invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1121-4

Silencing USP22 by asymmetric structure of interfering RNA inhibits proliferation and induces cell cycle arrest in bladder cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1121-4

Dubbing SAGA unveils new epigenetic crosstalk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1121-4

USP22 regulates cell proliferation by deubiquitinating the transcriptional regulator FBP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1121-4

The ubiquitin hydrolase USP22 contributes to 3'-end processing of JAK-STAT-inducible genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1121-4

USP22 acts as an oncogene by the activation of BMI-1-mediated INK4a/ARF pathway and Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1121-4

Prognostic significance of AEG-1 expression in colorectal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1121-4

Purification, characterization and anticancer activity of a polysaccharide from Panax ginseng

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1121-4

Panax ginseng polysaccharide suppresses metastasis via modulating Twist expression in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1121-4

The inhibitory effect of a polysaccharide from Codonopsis pilosula on tumor growth and metastasis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1121-4

Extraction, purification and antitumor activity of a water-soluble polysaccharide from the roots of Polygala tenuifolia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1121-4

Characterization and antitumor activities of a polysaccharide from the rhizoma of Menispermum dauricum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1121-4

Anti-ovarian cancer potential of two acidic polysaccharides from the rhizoma of Menispermum dauricum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1121-4

Natural history of cervical human papillomavirus lesions does not substantiate the biologic relevance of the Bethesda System

21 January 2018

1 reference

12 December 2020

Expression of Beclin 1 and LC3 in FIGO stage I-II cervical squamous cell carcinoma and relationship to survival

1 reference

12 December 2020

Elevated expression of astrocyte elevated gene-1 (AEG-1) is correlated with cisplatin-based chemoresistance and shortened outcome in patients with stages III-IV serous ovarian carcinoma

1 reference

12 December 2020

High expression of M3 muscarinic acetylcholine receptor is a novel biomarker of poor prognostic in patients with non-small cell lung cancer

1 reference

12 December 2020

Reducing death from cancer: what will it take?

1 reference

12 December 2020

Purification and antitumor activity of two acidic polysaccharides from the roots of Polygala tenuifolia

1 reference

12 December 2020

T-cell infiltration and expressions of T lymphocyte co-inhibitory B7-H1 and B7-H4 molecules among colorectal cancer patients in northeast China's Heilongjiang province

1 reference

12 December 2020

10.1007/S13277-013-1121-4

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018